[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Electronic Drug Delivery Systems Market Size, Trends, Analysis, and Outlook By Product (Wearable Infusion Pumps, Auto Injectors, Injection Pens, Inhalers), By Application (Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Country, Segment, and Companies, 2024-2032

April 2024 | 205 pages | ID: EFF56F290C45EN
VPAResearch

US$ 3,582.00 US$ 3,980.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Electronic Drug Delivery Systems market size is poised to register 8.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Electronic Drug Delivery Systems market across By Product (Wearable Infusion Pumps, Auto Injectors, Injection Pens, Inhalers), By Application (Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

The electronic drug delivery systems market is driven by the increasing demand for precise and patient-controlled drug delivery solutions, advancements in microfluidics and wearable technologies, and the growing interest in personalized medicine and targeted therapies. By 2030, the market is anticipated to witness significant growth, fueled by innovations in electronic inhalers, transdermal patches, and smart infusion pumps. Further, expanding applications in respiratory diseases, diabetes management, and pain relief are expected to drive market expansion, enabling patients, caregivers, and healthcare providers to administer medications, monitor adherence, and optimize treatment outcomes through electronic drug delivery systems that offer dose accuracy, therapy customization, and connectivity for real-time monitoring and feedback in medication management and chronic disease management.

Electronic Drug Delivery Systems Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Electronic Drug Delivery Systems market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Electronic Drug Delivery Systems survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Electronic Drug Delivery Systems industry.

Key market trends defining the global Electronic Drug Delivery Systems demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Electronic Drug Delivery Systems Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The Electronic Drug Delivery Systems industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Electronic Drug Delivery Systems companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Electronic Drug Delivery Systems industry

Leading Electronic Drug Delivery Systems companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Electronic Drug Delivery Systems companies.

Electronic Drug Delivery Systems Market Study- Strategic Analysis Review

The Electronic Drug Delivery Systems market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Electronic Drug Delivery Systems Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Electronic Drug Delivery Systems industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

Electronic Drug Delivery Systems Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America Electronic Drug Delivery Systems Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Electronic Drug Delivery Systems market segments. Similarly, Strong market demand is encouraging Canadian Electronic Drug Delivery Systems companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Electronic Drug Delivery Systems market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Electronic Drug Delivery Systems Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Electronic Drug Delivery Systems industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Electronic Drug Delivery Systems market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Electronic Drug Delivery Systems Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Electronic Drug Delivery Systems in Asia Pacific. In particular, China, India, and South East Asian Electronic Drug Delivery Systems markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America Electronic Drug Delivery Systems Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Electronic Drug Delivery Systems Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Electronic Drug Delivery Systems market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Electronic Drug Delivery Systems.

Electronic Drug Delivery Systems Market Company Profiles

The global Electronic Drug Delivery Systems market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bayer AG, Becton, Dickinson and Company, Elcam Medical Industries, Gerresheimer AG, Insulet Corp, Medtronic plc, Novo Nordisk A/S, Sanofi SA, Unilife Corp.

Recent Electronic Drug Delivery Systems Market Developments

The global Electronic Drug Delivery Systems market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Electronic Drug Delivery Systems Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Product

Wearable Infusion Pumps

Auto Injectors

Injection Pens

Inhalers

By Application

Diabetes

Cardiovascular Disease

Respiratory Disorders

Multiple Sclerosis

Others

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

Bayer AG

Becton, Dickinson and Company

Elcam Medical Industries

Gerresheimer AG

Insulet Corp

Medtronic plc

Novo Nordisk A/S

Sanofi SA

Unilife Corp

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Electronic Drug Delivery Systems Market Overview and Key Findings, 2024
1.2 Electronic Drug Delivery Systems Market Size and Growth Outlook, 2021- 2030
1.3 Electronic Drug Delivery Systems Market Growth Opportunities to 2030
1.4 Key Electronic Drug Delivery Systems Market Trends and Challenges
  1.4.1 Electronic Drug Delivery Systems Market Drivers and Trends
  1.4.2 Electronic Drug Delivery Systems Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Electronic Drug Delivery Systems Companies

2. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SIZE OUTLOOK TO 2030

2.1 Electronic Drug Delivery Systems Market Size Outlook, USD Million, 2021- 2030
2.2 Electronic Drug Delivery Systems Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Wearable Infusion Pumps
Auto Injectors
Injection Pens
Inhalers
By Application
Diabetes
Cardiovascular Disease
Respiratory Disorders
Multiple Sclerosis
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Electronic Drug Delivery Systems Market, 2025
5.2 Asia Pacific Electronic Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Electronic Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Electronic Drug Delivery Systems Market, 2025
5.5 Europe Electronic Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.6 Europe Electronic Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Electronic Drug Delivery Systems Market, 2025
5.8 North America Electronic Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.9 North America Electronic Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Electronic Drug Delivery Systems Market, 2025
5.11 South America Pacific Electronic Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.12 South America Electronic Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Electronic Drug Delivery Systems Market, 2025
5.14 Middle East Africa Electronic Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Electronic Drug Delivery Systems Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Electronic Drug Delivery Systems Market Size Outlook and Revenue Growth Forecasts
6.2 US Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Electronic Drug Delivery Systems Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Electronic Drug Delivery Systems Industry Drivers and Opportunities

7. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. ELECTRONIC DRUG DELIVERY SYSTEMS COMPANY PROFILES

8.1 Profiles of Leading Electronic Drug Delivery Systems Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bayer AG
Becton, Dickinson and Company
Elcam Medical Industries
Gerresheimer AG
Insulet Corp
Medtronic plc
Novo Nordisk A/S
Sanofi SA
Unilife Corp.

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications